🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase II, randomized, open-label, multi-center study evaluating t...
Status
Withdrawn
Location
Multiple Locations
Start Date
2011-10
Trial ID
NCT01137994
Treatments Being Tested
The objective of this phase II study is to gain first information on the ef...
Status
Terminated
Location
Dep. of Medicine I , Division of Oncology
Start Date
2010-09
Trial ID
NCT01161368
Treatments Being Tested
Phase I part: to determine the recommended dose, and observe the preliminar...
Status
Completed
Location
Department of Oncology,National Taiwan University Hospital
Start Date
2008-11-24
Trial ID
NCT00912275
Treatments Being Tested
The purpose of the study is to investigate safety and efficiency of the tri...
Status
Terminated
Location
Onkologie Ravensburg
Start Date
2010-10
Trial ID
NCT01238029
Treatments Being Tested
Despite these initial positive signals in recent statistics, breast cancer ...
Status
Completed
Location
Dr. Guillermo Lerzo
Start Date
2009-11
Trial ID
NCT01050322
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy work in different ways to stop the gr...
Status
Completed
Location
Memorial Sloan Kettering
Start Date
2008-09
Trial ID
NCT00795678
The purpose of this study is to identify the highest tolerable dose of nera...
Status
Completed
Location
Highlands Oncology Group
Start Date
2008-04-29
Trial ID
NCT00706030
Treatments Being Tested
Pyrotinib Plus Vinorelbine Versus Lapatinib Plus Capecitabine...
Status
Completed
Location
Fudan University Shanghai Cancer Center
Start Date
2020-01-15
Trial ID
NCT04850625
The hypothesis of this study is to discover if the all-oral therapy with ap...
Status
Unknown
Location
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Start Date
2016-06
Trial ID
NCT02768415
Treatments Being Tested
RATIONALE: Lapatinib may stop the growth of tumor cells by blocking some of...
Status
Completed
Location
Centre de Lutte Contre le Cancer Georges-Francois Leclerc
Start Date
2007-06
Trial ID
NCT00513058
Treatments Being Tested